A Middle Tennessee clinic is among seven health facilities that received drugs from a compounding drug company suspected of being responsible for a cluster of infections in patients injected with a steroid, the state health department disclosed today.
At this time, the department is not certain of the number of patients who may have received injections, said agency spokesman Woody McMillin, adding the department was also not aware of any adverse events among Tennessee patients who received the suspect medications.
continue to read here
No comments:
Post a Comment